Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative-Reference-Cited by-同舟云学术

Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative

Published:2020-09 Issue:9 Volume:23 Page:1128-1136
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Orsini Lucinda S.,Berger Marc,Crown William,Daniel Gregory,Eichler Hans-Georg,Goettsch Wim,Graff Jennifer,Guerino John,Jonsson Pall,Lederer Nirosha Mahendraratnam,Monz Brigitta,Mullins C. Daniel,Schneeweiss Sebastian,Brunt David Van,Wang Shirley V.,Willke Richard J.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference22 articles.

1. Accountability for reasonableness;Daniels;BMJ,2000

2. Policies for use of real-world data in health technology assessment (HTA): a comparative study of six HTA agencies;Makady;Value Health,2017

3. Real-world evidence: useful in the real world of US payer decision making? How? When? And what studies?;Malone;Value Health,2018

4. Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1.0;Wang;Value Health,2017

5. Improving the transparency of prognosis research: the role of reporting, data sharing, registration, and protocols;Peat;PLoS Med,2014

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generating real‐world evidence on diabetes technology using the CareLink Personal data management system;Diabetes, Obesity and Metabolism;2024-09-04

2. The maze of real-world evidence frameworks: from a desert to a jungle! An environmental scan and comparison across regulatory and health technology assessment agencies;Journal of Comparative Effectiveness Research;2024-09

3. Transparency in the secondary use of health data: Assessing the status quo of guidance and best practices;2024-08-11

4. A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks;Therapeutic Innovation & Regulatory Science;2024-07-25

5. Generalizability in real‐world trials;Clinical and Translational Science;2024-07